Older adults have been shown to be at greatest risk for severe outcomes from COVID-19. In response to the onset of the coronavirus pandemic, the Canadian Longitudinal Study on Aging (CLSA) expanded the scope of its research, launching a comprehensive questionnaire-based study to investigate the pandemic impacts on older adults, exploring how they cope, the effects on their physical and mental health, and changes to how they access health-care services. In fall 2020, a partnership with the COVID-19 Immunity Task Force launched the CLSA COVID-19 Seroprevalence Study. This study collects and analyzes blood samples from more than 19,000 CLSA participants in 10 provinces, helping to elucidate how widespread SARS-CoV-2 infection is among adults over age 50. A third study, funded by the Canadian Institutes of Health Research, will examine the impacts of SARS-CoV-2 on brain health.
Join us to learn more about the CLSA’s research response to coronavirus. The discussion will include an overview of all three COVID-19 studies, an introduction to the COVID-19 baseline data dashboard, and a Q&A for researchers to learn more about the forthcoming data.